This report looks at the clinical trials tech companies serving pharmaceutical companies and CROs.
CB Insights identified 100+ clinical trials tech companies addressing 8 technology priorities, from decentralized clinical trials to remote patient monitoring, that pharma companies and contract research organizations (CROs) face. The purpose of the analysis is to provide technology buyers with an overview of the technology landscape and its market participants.
Key themes explored in this report include:
- Hyperspecific recruitment: As drugs become more targeted to specific populations, patient recruitment and enrollment will become more challenging. Tech solutions can ease the burden.
- Data, data, data: Collecting, accessing, and leveraging novel data sources — from real-world data or remote patient monitoring — can improve the speed and success rates of clinical trials.
- Decentralized trials: Accelerated by Covid-19, emerging technologies are enabling lower-cost decentralized trials. Digital twins and biosimulations may even push components of trials to be entirely virtual.
Download the Tech Market Map report using the sidebar to see our overview of this technology market.
Want the full expert post? Become a CB Insights customer.
If you’re already a customer, log in here.